Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1960 1
1972 1
1973 1
1974 1
1977 4
1979 1
1980 2
1981 2
1985 2
1986 1
1988 1
1990 1
1991 1
1992 1
1993 2
1996 1
1997 1
1999 1
2001 1
2002 4
2003 1
2004 1
2005 3
2006 2
2007 1
2008 2
2009 1
2010 1
2011 2
2013 1
2014 2
2015 3
2016 2
2017 4
2018 3
2019 4
2020 11
2021 5
2022 3
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group. Green JB, et al. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. N Engl J Med. 2015. PMID: 26052984 Free article. Clinical Trial.
Modeling neurodegenerative disorders in zebrafish.
Bashirzade AA, Zabegalov KN, Volgin AD, Belova AS, Demin KA, de Abreu MS, Babchenko VY, Bashirzade KA, Yenkoyan KB, Tikhonova MA, Amstislavskaya TG, Kalueff AV. Bashirzade AA, et al. Neurosci Biobehav Rev. 2022 Jul;138:104679. doi: 10.1016/j.neubiorev.2022.104679. Epub 2022 Apr 28. Neurosci Biobehav Rev. 2022. PMID: 35490912 Review.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
At baseline, 791 (7.9%) had macroalbuminuria and mean eGFR was 76.9 mL/min per 1.73 m(2) (SD 22.7). During a median follow-up of 5.4 years (IQR 5.1-5.9) comprising 51 820 person-years, the renal outcome developed in 848 (17.1%) participants at an incidence rate of 3.5 per …
At baseline, 791 (7.9%) had macroalbuminuria and mean eGFR was 76.9 mL/min per 1.73 m(2) (SD 22.7). During a median follow-up of 5.4 …
Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
Halperin JL, Hankey GJ, Wojdyla DM, Piccini JP, Lokhnygina Y, Patel MR, Breithardt G, Singer DE, Becker RC, Hacke W, Paolini JF, Nessel CC, Mahaffey KW, Califf RM, Fox KA; ROCKET AF Steering Committee and Investigators. Halperin JL, et al. Circulation. 2014 Jul 8;130(2):138-46. doi: 10.1161/CIRCULATIONAHA.113.005008. Epub 2014 Jun 3. Circulation. 2014. PMID: 24895454 Free article. Clinical Trial.
Zebrafish models of impulsivity and impulse control disorders.
de Abreu MS, C V V Giacomini A, Genario R, Fontana BD, Parker MO, Marcon L, Scolari N, Bueno B, Demin KA, Galstyan D, Kolesnikova TO, Amstislavskaya TG, Zabegalov KN, Strekalova T, Kalueff AV. de Abreu MS, et al. Eur J Neurosci. 2020 Nov;52(10):4233-4248. doi: 10.1111/ejn.14893. Epub 2020 Aug 5. Eur J Neurosci. 2020. PMID: 32619029 Review.
DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens.
Lakstygal AM, Kolesnikova TO, Khatsko SL, Zabegalov KN, Volgin AD, Demin KA, Shevyrin VA, Wappler-Guzzetta EA, Kalueff AV. Lakstygal AM, et al. ACS Chem Neurosci. 2019 May 15;10(5):2144-2159. doi: 10.1021/acschemneuro.8b00615. Epub 2019 Jan 10. ACS Chem Neurosci. 2019. PMID: 30566832 Review.
These drugs are competitive antagonists of acetylcholine muscarinic (M-) receptors that potently modulate the central nervous system (CNS). Currently used clinically to treat vomiting, nausea, and bradycardia, as well as alongside other anesthetics to avoid vagal inhibitio …
These drugs are competitive antagonists of acetylcholine muscarinic (M-) receptors that potently modulate the central nervous system …
Understanding CNS Effects of Antimicrobial Drugs Using Zebrafish Models.
Kotova MM, Galstyan DS, Kolesnikova TO, de Abreu MS, Amstislavskaya TG, Strekalova T, Petersen EV, Yenkoyan KB, Demin KA, Kalueff AV. Kotova MM, et al. Vet Sci. 2023 Jan 29;10(2):96. doi: 10.3390/vetsci10020096. Vet Sci. 2023. PMID: 36851400 Free PMC article. Review.
The role of auditory and vibration stimuli in zebrafish neurobehavioral models.
Wang J, Wang D, Hu G, Yang L, Liu Z, Yan D, Serikuly N, Alpyshov E, Demin KA, Strekalova T, Gil Barcellos LJ, Barcellos HHA, Amstislavskaya TG, de Abreu MS, Kalueff AV. Wang J, et al. Behav Processes. 2021 Dec;193:104505. doi: 10.1016/j.beproc.2021.104505. Epub 2021 Sep 20. Behav Processes. 2021. PMID: 34547376 Review.
Current State of Modeling Human Psychiatric Disorders Using Zebrafish.
Costa FV, Kolesnikova TO, Galstyan DS, Ilyin NP, de Abreu MS, Petersen EV, Demin KA, Yenkoyan KB, Kalueff AV. Costa FV, et al. Int J Mol Sci. 2023 Feb 6;24(4):3187. doi: 10.3390/ijms24043187. Int J Mol Sci. 2023. PMID: 36834599 Free PMC article. Review.
86 results